EPW
COLL icon

Evolve Private Wealth’s Collegium Pharmaceutical COLL Stock Holding History

Evolve Private Wealth’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$900K Buy
24,865
+1,345
+6% +$46K 0.06% 311
2026
Q1 		$778K Buy
23,520
+1,313
+6% +$55.6K 0.04% 403
2025
Q4 		$1.03M Buy
+22,207
New +$929K 0.06% 288

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Evolve Private Wealth's COLL Position: Q2 2026 in Review

Evolve Private Wealth increased its Collegium Pharmaceutical (COLL) stake by 5.7% in Q2 2026, buying an estimated $46K and bringing the position to 24,865 shares worth $900K. The position accounts for 0.06% of the portfolio, ranked #311.

Evolve Private Wealth first reported a position in COLL in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.03M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Evolve Private Wealth held 24,865 shares of Collegium Pharmaceutical worth $900K as of Q2 2026.
  • Evolve Private Wealth bought 1,345 Collegium Pharmaceutical shares in Q2 2026, an estimated $46K.
  • Collegium Pharmaceutical made up 0.06% of Evolve Private Wealth's portfolio in Q2 2026, its #311 holding.
  • Evolve Private Wealth first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Collegium Pharmaceutical position peaked at $1.03M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.